Comparing the Incomparable? A Systematic Review of Competing Techniques for Converting Descriptive Measures of Health Status into QALY-Weights

Background . Algorithms for converting descriptive measures of health status into quality-adjusted life year (QALY)—weights are now widely available, and their application in economic evaluation is increasingly commonplace. The objective of this study is to describe and compare existing conversion algorithms and to highlight issues bearing on the derivation and interpretation of the QALY-weights so obtained. Methods . Systematic review of algorithms for converting descriptive measures of health status into QALY-weights. Results . The review identified a substantial body of literature comprising 46 derivation studies and 16 studies that provided evidence or commentary on the validity of conversion algorithms. Conversion algorithms were derived using 1 of 4 techniques: 1) transfer to utility regression, 2) response mapping, 3) effect size translation, and 4) “revaluing” outcome measures using preference-based scaling techniques. Although these techniques differ in their methodological/theoretical tradition, data requirements, and ease of derivation and application, the available evidence suggests that the sensitivity and validity of derived QALY-weights may be more dependent on the coverage and sensitivity of measures and the disease area/patient group under evaluation than on the technique used in derivation. Conclusions . Despite the recent proliferation of conversion algorithms, a number of questions bearing on the derivation and interpretation of derived QALY-weights remain unresolved. These unresolved issues suggest directions for future research in this area. In the meantime, analysts seeking guidance in selecting derived QALY-weights should consider the validity and feasibility of each conversion algorithm in the disease area and patient group under evaluation rather than restricting their choice to weights from a particular derivation technique.

[1]  R. Kreienberg,et al.  A preference-based index for the SF-12. , 2006, Health economics.

[2]  Patrick W. Sullivan,et al.  US General Population Preferences in a Nationally Representative Sample , 2009 .

[3]  J. Richardson,et al.  Cost utility analysis: what should be measured? , 1994, Social science & medicine.

[4]  R. Osborne,et al.  The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of Health-Related Quality of Life , 1999, Quality of Life Research.

[5]  M. Hlatky,et al.  Quality of life and time trade-off utility measures in patients with coronary artery disease. , 2003, American heart journal.

[6]  A. Kulkarni,et al.  Distribution-based and anchor-based approaches provided different interpretability estimates for the Hydrocephalus Outcome Questionnaire. , 2006, Journal of clinical epidemiology.

[7]  P. Dolan Modelling valuations for health states , 1997 .

[8]  J. R. Bult,et al.  Heterogeneity in the Relationship between the Standard-gamble Utility Measure and Health-status Dimensions , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  Rob Carter,et al.  Assessing Cost-Effectiveness – Mental Health: Introduction to the Study and Methods , 2004 .

[10]  N. Sengupta,et al.  Mapping the SF-12 to the HUI3 and VAS in a Managed Care Population , 2004, Medical care.

[11]  Oliver Rivero-Arias,et al.  Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[12]  William F Lawrence,et al.  Predicting EuroQoL EQ-5D Preference Scores from the SF-12 Health Survey in a Nationally Representative Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  S. Sullivan,et al.  Comparison of Directly Elicited Preferences to Preferences Derived from the SF-36 in Adults with Asthma , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

[14]  J. Brazier,et al.  The Estimation of a Preference-Based Measure of Health From the SF-12 , 2004, Medical care.

[15]  M. Weinstein,et al.  Preference-based measures in economic evaluation in health care. , 2000, Annual review of public health.

[16]  N. Sengupta,et al.  Evaluating Quality-Adjusted Life Years , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.

[17]  Leonie Segal,et al.  Can we reduce disease burden from osteoarthritis? , 2004, The Medical journal of Australia.

[18]  Graeme Hawthorne,et al.  Item-based versus subscale-based mappings from the SF-36 to a preference-based quality of life measure. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[19]  R. Osborne,et al.  Priority setting in Osteoarthritis , 2004 .

[20]  Marthe R. Gold,et al.  Mapping the SF-12 to Preference-Based Instruments: Convergent Validity in a Low-Income, Minority Population , 2003, Medical care.

[21]  D. Shepard,et al.  Changes in Quality of Life for Pregnant Women in Substance User Treatment: Developing a Quality of Life Index for the Addictions , 2005, Substance use & misuse.

[22]  S. Gabriel,et al.  Health-related Quality of Life in Economic Evaluations for Osteoporosis , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  Andrew M Jones,et al.  Inequalities in self-reported health: validation of a new approach to measurement. , 2003, Journal of health economics.

[24]  C. Gross,et al.  Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients , 2004, Quality of Life Research.

[25]  Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia , 2005, Health and quality of life outcomes.

[26]  M. Gold Cost-effectiveness in health and medicine , 2016 .

[27]  G. Andrews,et al.  Using the effect size to model change in preference values from descriptive health status , 2004, Quality of Life Research.

[28]  Rob Carter,et al.  Cost-Effectiveness of Cognitive Behavioural Therapy and Selective Serotonin Reuptake Inhibitors for Major Depression in Children and Adolescents , 2004, The Australian and New Zealand journal of psychiatry.

[29]  John Brazier,et al.  A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. , 2003, Health economics.

[30]  A. Shmueli,et al.  Subjective Health Status and Health Values in the General Population , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  T. Vos,et al.  Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder , 2004, The Australian and New Zealand journal of psychiatry.

[32]  J. Brazier,et al.  Deriving a preference-based single index from the UK SF-36 Health Survey. , 1998, Journal of clinical epidemiology.

[33]  Luis Prieto,et al.  Health and Quality of Life Outcomes , 2005 .

[34]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[35]  E. Halpern,et al.  Comparison of Preference-Based Utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after Treatment of Patients with Intermittent Claudication , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[36]  T. Vos,et al.  Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder. , 2004, The Australian and New Zealand journal of psychiatry.

[37]  T. Ganiats,et al.  Comparison of Measured Utility Scores and Imputed Scores From the SF-36 in Patients With Rheumatoid Arthritis , 2005, Medical care.

[38]  T. Tosteson,et al.  Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among Spine Patient Outcomes Research Trial (SPORT) participants , 2005, Quality of Life Research.

[39]  J. Bosch,et al.  The Relationship between Descriptive and Valuational Quality-of-life Measures in Patients with Intermittent Claudication , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[40]  Mark Sculpher,et al.  Estimating utility data from clinical indicators for patients with stable angina , 2005, The European Journal of Health Economics.

[41]  D A Revicki,et al.  Relationship between health utility and psychometric health status measures. , 1992, Medical care.

[42]  R. Deyo,et al.  The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. , 2002, Health economics.

[43]  J. Ware SF-36 health survey: Manual and interpretation guide , 2003 .

[44]  T. Vos,et al.  Cost-Effectiveness of Dexamphetamine and Methylphenidate for the Treatment of Childhood Attention Deficit Hyperactivity Disorder , 2004 .

[45]  M C Weinstein,et al.  Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning. , 1996, Medical care.

[46]  N. Duan,et al.  Can Utility-Weighted Health-Related Quality-of-Life Estimates Capture Health Effects of Quality Improvement for Depression? , 2001, Medical care.

[47]  A. Shmueli The SF-36 Profile and Health-Related Quality of Life: An Interpretative Analysis , 1998, Quality of Life Research.

[48]  Haomiao Jia,et al.  Mapping the SF-12 to the EuroQol EQ-5D Index in a National US Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[49]  T. Vos,et al.  Assessing cost-effectiveness of drug interventions for schizophrenia. , 2005, The Australian and New Zealand journal of psychiatry.

[50]  C. Sherbourne,et al.  Estimation of utilities for the effects of depression from the SF-12. , 2000, Medical care.

[51]  M Johannesson,et al.  The Relationship between Health-state Utilities and the SF-12 in a General Population , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[52]  M Sculpher,et al.  PMH45 MAPPING UTILITY SCORES FROM THE EQ-5D AND SF-6D ONTO THE SCHIZOPHRENIA QUALITY OF LIFE SCALE , 2004 .

[53]  P. Mohr,et al.  Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores , 2004, Schizophrenia Research.

[54]  Ross D Crosby,et al.  Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[55]  Use of the TTU is questionable , 2004, The Medical journal of Australia.

[56]  W F Lawrence,et al.  Predicting Quality of Well-being Scores from the SF-36 , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[57]  Barrett T. Kitch,et al.  Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. , 2001, The Journal of allergy and clinical immunology.

[58]  Amir Shmueli The Relationship between the Visual Analog Scale and the SF-36 Scales in the General Population: An Update , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.